Literature DB >> 4987168

The distribution kinetics of triiodothyronine: studies of euthyroid subjects with decreased plasma thyroxine-binding globulin and patients with Graves' disease.

R R Cavalieri, M Steinberg, G L Searle.   

Abstract

The kinetics of distribution of 3,3',5-triiodo-L-thyronine (T(3)) have been studied employing both a single-injection and a continuous infusion of T(3-) (131)I. External monitoring of radioactivity in the liver during the infusion permitted estimation of the hepatic distribution volume (V(H)) and the one-way hepatic clearance (C(H)) of the hormone. Among 10 euthyroid control subjects, V(H) averaged 2.07 liters +/-0.50 (SD), and the mean value for C(H), 231 ml of plasma per min (+/-64). In three euthyroid men whose plasma showed decreased binding capacity by thyroxine-binding globulin (TBG) abnormally high V(H) and C(H) values were found, the increase in C(H) being proportional to the decrease in binding activity by plasma proteins. Among all 13 subjects, there was a high correlation (+ 0.86) between C(H) and the proportion of free hormone in plasma, measured in vitro. In four patients with hyperthyroid Graves' disease V(H) ranged from 3.2 to 4.2 liters and C(H) was elevated in every case, averaging 989 ml/min. The increase in C(H) in this group was out of proportion to the elevation of free hormone fraction in plasma. Seven patients who were either euthyroid or hypothyroid after treatment of Graves' disease showed a slight but significant increase in C(H) compared with the euthyroid controls without Graves' disease. The percentage of free hormone in the plasma of the treated group was normal or low and therefore could not explain the persistent elevation in unidirectional hepatic clearance observed. The rate of accumulation of labeled T(3) in the tissues of the thigh during the interval from 10 to 60 min of the sustaining infusion of tracer was slow compared to the rate of equilibration in the liver and did not differ significantly among the various groups studied. These latter findings suggest that in slowly equilibrating tissues such as the thigh the kinetics of T(3) distribution are relatively insensitive to alterations in hormone-binding activity by plasma proteins.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4987168      PMCID: PMC322572          DOI: 10.1172/JCI106320

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  25 in total

1.  Disappearance of I-131-triiodo-thyronine from the plasma in the presence of fever.

Authors:  J G WISWELL; V CORONHO
Journal:  J Clin Endocrinol Metab       Date:  1962-06       Impact factor: 5.958

2.  Regulation of the peripheral metabolism of the thyroid hormones.

Authors:  S H INGBAR; N FREINKEL
Journal:  Recent Prog Horm Res       Date:  1960

3.  Studies of thyroid function and the peripheral metabolism of I 131-labeled thyroxine in patients with treated Graves disease.

Authors:  S H INGBAR; N FREINKEL
Journal:  J Clin Invest       Date:  1958-11       Impact factor: 14.808

4.  The metabolism of triiodothyronine in Graves' disease.

Authors:  I B HALES; B M DOBYNS
Journal:  J Clin Endocrinol Metab       Date:  1960-01       Impact factor: 5.958

5.  The distribution and metabolism of thyroxine and 3:5:3'-triiodothyronine in the rabbit.

Authors:  K Brown-Grant; J R Tata
Journal:  J Physiol       Date:  1961-06       Impact factor: 5.182

6.  Determination of iodine compounds in serum. I. Serum thyroxine in the presence of some iodine contaminants.

Authors:  V J PILEGGI; N D LEE; O J GOLUB; R J HENRY
Journal:  J Clin Endocrinol Metab       Date:  1961-10       Impact factor: 5.958

7.  The kinetics of distribution between plasma and liver of 131-I-labeled L-thyroxine in man: observations of subjects with normal and decreased serum thyroxine-binding globulin.

Authors:  R R Cavalieri; G L Searle
Journal:  J Clin Invest       Date:  1966-06       Impact factor: 14.808

8.  Role of thyroxine-binding globulin in the early distribution of thyroxine and triiodothyronine.

Authors:  B U Musa; R S Kumar; J T Dowling
Journal:  J Clin Endocrinol Metab       Date:  1969-05       Impact factor: 5.958

9.  A simplified method for estimating free-thyroxine fraction in serum.

Authors:  R R Cavalieri; J N Castle; G L Searle
Journal:  J Nucl Med       Date:  1969-09       Impact factor: 10.057

10.  Estimation of rapidly exchangeable cellular thyroxine from the plasma disappearance curves of simultaneously administered thyroxine-131-I and albumin-125-I.

Authors:  J H Oppenheimer; G Bernstein; J Hasen
Journal:  J Clin Invest       Date:  1967-05       Impact factor: 14.808

View more
  5 in total

1.  Circulating 3,3', 5'-triiodothyronine (reverse T3) in the human newborn.

Authors:  I J Chopra; J Sack; D A Fisher
Journal:  J Clin Invest       Date:  1975-06       Impact factor: 14.808

2.  Relative rates of transcapillary movement of free thyroxine, protein-bound thyroxine, thyroxine-binding proteins, and albumin.

Authors:  C H Irvine; M W Simpson-Morgan
Journal:  J Clin Invest       Date:  1974-07       Impact factor: 14.808

3.  Role of serum carrier proteins in the peripheral metabolism and tissue distribution of thyroid hormones in familial dysalbuminemic hyperthyroxinemia and congenital elevation of thyroxine-binding globulin.

Authors:  R Bianchi; G Iervasi; A Pilo; F Vitek; M Ferdeghini; F Cazzuola; G Giraudi
Journal:  J Clin Invest       Date:  1987-08       Impact factor: 14.808

4.  Simultaneous measurement of thyroxine and triiodothyronine peripheral turnover kinetics in man.

Authors:  J T Nicoloff; J C Low; J H Dussault; D A Fisher
Journal:  J Clin Invest       Date:  1972-03       Impact factor: 14.808

5.  Peripheral serum thyroxine, triiodothyronine and reverse triiodothyronine kinetics in the low thyroxine state of acute nonthyroidal illnesses. A noncompartmental analysis.

Authors:  E M Kaptein; W J Robinson; D A Grieb; J T Nicoloff
Journal:  J Clin Invest       Date:  1982-03       Impact factor: 14.808

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.